FTC sues big pharmacy gain administrators more than insulin prices The agency introduced motion towards Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of life-conserving insulin medications. Elevance lowers steering on ‘unprecedented’ Medicaid troubles Executives said the enhanced exp... https://label-the-figure-with-the63963.ambien-blog.com/36923541/considerations-to-know-about-healthcare-news